[O-31] Oral Session 31
Clinical trial and Regenerative medicine 1 E

[O-31-6] A phase I clinical trial of intrathecal injection of recombinant human HGF in subjects with ALS

^○Hitoshi Warita¹, Masaaki Kato¹, Ryuta Asada², Atsuko Yamashita³, Hayata Hayata³, Kiichi Adachi³, Masashi Aoki¹ (1.Department of Neurology, Tohoku University Hospital, Japan, 2.Innovative and Clinical Research Promotion Center, Gifu University Hospital, 3.Kringle Pharma)